Blood cancer Clinical Trials in Houston, TX

As of September 2026, 183 paid clinical trials are recruiting for Blood cancer in Houston, Texas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 1, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

184 clinical trials for Blood cancer

·Clear filters·

Email me when a new blood cancer trial opens in Houston, TX.

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

for NHL

Sites in Houston +8 more locations

Sponsor: Indapta Therapeutics, INC.

Sex: All·Age: 18+

Code: NCT06119685·Phase 1, Phase 2·Recruiting·Listed Nov 2023

Apply to this trial

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

for Solid Tumors

Sites in Houston +7 more locations

Sponsor: Incyte Corporation

Sex: All·Age: 18+

Code: NCT07195916·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

for Lymphoma

Sites in Houston +7 more locations

Sponsor: Treeline Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT07082803·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)

for AML

Sites in Houston +4 more locations

Sponsor: CERo Therapeutics Holdings, Inc.

Sex: All·Age: 18 - 85

Code: NCT06834282·Phase 1·Recruiting·Listed Feb 2025

Apply to this trial

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

for B-cell Acute Lymphoblastic Leukemia

Sites in Houston +10 more locations

Sponsor: Vironexis Biotherapeutics Inc.

Sex: All·Age: 13 - 90

Code: NCT06533579·Phase 1, Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

for Acute Myeloid Leukemia

Sites in Houston +6 more locations

Sponsor: Debiopharm International SA

Sex: All·Age: 18+

Code: NCT06969430·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

A Study of BGB-11417 in Participants With Myeloid Malignancies

for Acute Myeloid Leukemia

Sites in Houston +3 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT04771130·Phase 1, Phase 2·Recruiting·Listed Feb 2021

Apply to this trial

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

for Myelodysplastic Syndromes

Sites in Houston +8 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT04419649·Phase 2·Recruiting·Listed Jun 2020

Apply to this trial

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

for Somatostatin Receptor Positive

Sites in Houston +2 more locations

Sponsor: ITM Solucin GmbH

Sex: All·Age: 24 Months - 18

Code: NCT06441331·Phase 1·Recruiting·Listed Jun 2024

Apply to this trial

Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma

for Multiple Myeloma

Sites in Houston +4 more locations

Sponsor: Heidelberg Pharma AG

Sex: All·Age: 18+

Code: NCT04879043·Phase 1, Phase 2·Recruiting·Listed May 2021

Apply to this trial

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

for Acute Myeloid Leukemia

Sites in Houston +5 more locations

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT06824168·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma

for Multiple Myeloma

Drug: Elranatamab

Sites in Houston +3 more locations

Sponsor: Celgene

Sex: All·Age: 18+

Code: NCT06988488·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment

for Acute Myeloid Leukemia

1 location in Houston

Sponsor: Taiho Oncology, Inc.

Sex: All·Age: 18+

Code: NCT04953897·Phase 1·Recruiting·Listed Jul 2021

Apply to this trial

Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment

for Acute Myeloid Leukemia

1 location in Houston

Sponsor: Taiho Oncology, Inc.

Sex: All·Age: 18+

Code: NCT04953910·Phase 1·Recruiting·Listed Jul 2021

Apply to this trial

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

for Non Hodgkin Lymphoma

Sites in Houston +7 more locations

Sponsor: Newave Pharmaceutical Inc

Sex: All·Age: 13+

Code: NCT04771572·Phase 1·Recruiting·Listed Feb 2021

Apply to this trial

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

for Acute Myeloid Leukemia

Sites in Houston +7 more locations

Sponsor: Chordia Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT05732103·Phase 1, Phase 2·Recruiting·Listed Feb 2023

Apply to this trial

Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes

for Acute Myeloid Leukemia

Sites in Houston +1 more location

Sponsor: Remedy Plan, Inc.

Sex: All·Age: 18+

Code: NCT07107126·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Houston +5 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT06419634·Phase 1·Recruiting·Listed May 2024

Apply to this trial

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

for Chronic Myelomonocytic Leukemia

Sites in Houston +6 more locations

Sponsor: Solu Therapeutics, Inc

Sex: All·Age: 18+

Code: NCT06950034·Phase 1·Recruiting·Listed Apr 2025

Apply to this trial

A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

for Myelofibrosis

Drug: Selinexor

Sites in Houston +6 more locations

Sponsor: Karyopharm Therapeutics Inc

Sex: All·Age: 18+

Code: NCT05980806·Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

Study of REM-422 in Patients With AML or Higher Risk MDS

for Myelodysplastic Syndromes

Sites in Houston +4 more locations

Sponsor: Remix Therapeutics

Sex: All·Age: 18+

Code: NCT06297941·Phase 1·Recruiting·Listed Mar 2024

Apply to this trial

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

for Myelofibrosis

Drug: Ruxolitinib

Sites in Houston +3 more locations

Sponsor: Cellenkos, Inc.

Sex: All·Age: 18+

Code: NCT05423691·Phase 1·Recruiting·Listed Jun 2022

Apply to this trial

Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib

for Myelofibrosis

Drug: Ruxolitinib

Sites in Houston +3 more locations

Sponsor: Telios Pharma, Inc.

Sex: All·Age: 18+

Code: NCT05280509·Phase 1, Phase 2·Recruiting·Listed Mar 2022

Apply to this trial

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

for Acute Myeloid Leukemia

Sites in Houston +4 more locations

Sponsor: Vincerx Pharma, Inc.

Sex: All·Age: 18+

Code: NCT06034275·Phase 1·Recruiting·Listed Sep 2023

Apply to this trial

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

for Castrate Resistant Prostate Cancer

Sites in Houston +5 more locations

Sponsor: Epigenetix, Inc.

Sex: All·Age: 18+

Code: NCT05488548·Phase 1·Recruiting·Listed Aug 2022

Apply to this trial

APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies

for Hematologic Malignancies

Sites in Houston +1 more location

Sponsor: Ascentage Pharma Group Inc.

Sex: All·Age: 18+

Code: NCT03537482·EARLY_Phase 1·Recruiting·Listed May 2018

Apply to this trial

A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

for Acute Myeloid Leukemia

Sites in Houston +2 more locations

Sponsor: Edgewood Oncology Inc.

Sex: All·Age: 18+

Code: NCT04243785·Phase 1·Recruiting·Listed Jan 2020

Apply to this trial

Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma

for T-cell Acute Lymphoblastic Leukemia

Drug: Daratumumab

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 12 - 30

Code: NCT07513129·Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML

for AML

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07508982·Phase 1, Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies

for Lymphoid

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18 - 75

Code: NCT07444632·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

A Study of Revumenib and Mezigdomide in People With Leukemia

for Leukemia

Drug: Mezigdomide

Sites in Houston +9 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 12+

Code: NCT07356154·Phase 1, Phase 2·Recruiting·Listed Jan 2026

Apply to this trial

Phase 2 Trial of Lisocabtagene Maraleucel for Minimal Residual Disease in Patients With Large B-cell Lymphoma

for Large B-cell Lymphoma

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07316010·Phase 2·Recruiting·Listed Jan 2026

Apply to this trial

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

for Acute Myeloid Leukemia

Sites in Houston +329 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT05564390·Phase 2·Recruiting·Listed Oct 2022

Apply to this trial

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Houston +215 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06317649·Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

for Hematopoietic and Lymphatic System Neoplasm

Sites in Houston, San Antonio +189 more locations

Sponsor: Children's Oncology Group

Sex: Female·Age: Up to 39

Code: NCT06513962·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Houston +171 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18 - 59

Code: NCT05554393·Phase 2·Recruiting·Listed Sep 2022

Apply to this trial

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for B Acute Lymphoblastic Leukemia

Sites in Houston, Austin +185 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: 365 Days - 25

Code: NCT03959085·Phase 3·Recruiting·Listed May 2019

Apply to this trial

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

for Acute Myeloid Leukemia

Sites in Houston, Austin +167 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 21

Code: NCT04293562·Phase 3·Recruiting·Listed Mar 2020

Apply to this trial

Project: Every Child for Younger Patients With Cancer

for Adrenal Gland Pheochromocytoma

Sites in Houston, Austin +225 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 25

Code: NCT02402244·Recruiting·Listed Mar 2015

Apply to this trial

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Houston, Dallas +43 more locations

Sponsor: PedAL BCU, LLC

Sex: All·Age: 29 Days - 21

Code: NCT05183035·Phase 3·Recruiting·Listed Jan 2022

Apply to this trial

Conditions in Blood cancer (Houston, TX)

Acute myeloid leukemia (AML)· 65 Myelodysplastic syndromes (MDS)· 39 Hematologic malignancy· 38 Non-Hodgkin lymphoma· 33 Multiple myeloma· 22 Leukemia (other)· 17 Diffuse large B-cell lymphoma (DLBCL)· 13 Myelofibrosis· 12 Chronic myelomonocytic leukemia· 11 Hodgkin lymphoma· 11 Chronic lymphocytic leukemia (CLL)· 10 Follicular lymphoma· 8 Acute lymphoblastic leukemia· 7 Myeloproliferative neoplasm· 7 Mantle cell lymphoma· 7 Small lymphocytic lymphoma· 6 Marginal zone lymphoma· 4 Burkitt lymphoma· 3